Table 2.

Age and marker distributions for all 181 ovarian cancer patients (differentiated by histology)

Median (10th, 90th percentile) (range)Histology (n = 181)
Age (y)Afamin (mg/L)ApoA-IV (mg/dL)CA125 (units/mL)*
Serous-epithelial (n = 55)62.6 (43.4-75.6) (22.7-80.7)54.8 (27.8-74.0) (4.7-90.3)7.7 (4.0-16.3) (0.3-29.5)400.0 (38.6-2,565.4) (15.8-13,060.0)
Endometrioid-epithelial (n = 12)65.6 (48.0-75.5) (41.2-82.5)59.0 (42.4-78.4) (40.2-83.8)9.1 (5.1-14.7) (4.8-21.6)181.8 (25.4-1,517.7) (24.4-1,899.0)
Mucinous-epithelial (n = 9)59.1 (50.6-71.1) (47.9-76.5)55.8 (26.3-70.4) (16.9-74.7)7.0 (4.7-15.7) (4.0-17.0)48.4 (27.5-144.7) (10.3-212.0)
Undifferentiated carcinoma (n = 9)73.8 (42.3-76.7) (40.4-77.4)52.7 (34.5-78.5) (24.4-85.2)8.9 (4.9-12.2) (3.2-14.0)383.0 (157.0-2,962.4) (65.0-9,908.0)
Adenocarcinoma (n = 31)62.4 (44.6-76.6) (35.2-84.5)58.2 (34.5-66.6) (23.6-78.1)9.4 (6.1-15.8) (1.5-19.1)1,050.0 (150.0-3,039.0) (35.9-8,261.0)
Others (n = 22)58.9 (36.1-76.9) (25.6-81.3)66.8 (39.1-85.5) (27.6-88.3)10.7 (5.2-22.6) (3.9-26.0)115.5 (13.2-1,335.7) (10.4-7,000.0)
Unknown (n = 43)57.8 (39.1-78.0) (20.7-88.2)55.1 (31.0-79.6) (12.7-96.0)10.5 (4.8-16.4) (1.7-18.2)196.0 (23.1-2,189.0) (13.6-27,070.0)
  • * P < 0.0001 for difference among all subtypes (ANOVA).

  • Mucinous adenocarcinoma, teratoma, gonadal stroma- and granulo-cellular tumors, clear-cell carcinoma, and mixed Mullerian tumor (all n < 4) and special forms (n = 11).